Education
About Us
Working with TipRanks
Follow Us
Biosyent Inc (TSE:RX)
:RX
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | C$ 35.03M | C$ 31.59M | C$ 27.93M | C$ 28.62M | C$ 22.33M |
| Gross Profit | C$ 27.86M | C$ 25.60M | C$ 22.86M | C$ 22.64M | C$ 17.42M |
| Operating Income | C$ 8.75M | C$ 7.47M | C$ 6.98M | C$ 8.18M | C$ 5.03M |
| EBITDA | C$ 10.43M | C$ 9.06M | C$ 7.43M | C$ 8.64M | C$ 5.54M |
| Net Income | C$ 7.27M | C$ 6.46M | C$ 5.46M | C$ 6.28M | C$ 3.80M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | C$ 15.94M | C$ 26.19M | C$ 28.70M | C$ 28.21M | C$ 25.58M |
| Total Assets | C$ 41.36M | C$ 41.53M | C$ 40.49M | C$ 37.17M | C$ 33.57M |
| Total Debt | C$ 1.04M | C$ 1.22M | C$ 1.40M | C$ 1.56M | C$ 1.71M |
| Net Debt | C$ -11.08M | C$ -6.76M | C$ -6.47M | C$ -16.48M | C$ -18.58M |
| Total Liabilities | C$ 6.36M | C$ 6.77M | C$ 7.12M | C$ 5.61M | C$ 6.78M |
| Stockholders' Equity | C$ 35.00M | C$ 34.76M | C$ 33.36M | C$ 31.55M | C$ 26.80M |
| Cash Flow | |||||
| Free Cash Flow | C$ 3.99M | C$ 4.88M | C$ 4.43M | C$ 4.58M | C$ 6.72M |
| Operating Cash Flow | C$ 8.66M | C$ 5.05M | C$ 4.95M | C$ 4.67M | C$ 6.89M |
| Investing Cash Flow | C$ 3.29M | C$ 883.85K | C$ -10.79M | C$ -4.84M | C$ 3.39M |
| Financing Cash Flow | C$ -7.83M | C$ -5.78M | C$ -4.37M | C$ -2.08M | C$ -3.37M |